Ebola vaccine trial will begin in Guinea

2015-03-05 19:36
(File, AP)

(File, AP)

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Geneva - The first large-scale trial of an Ebola vaccine will begin in Guinea at the weekend, the World Health Organisation said on Thursday, weeks after a similar test kicked off in neighbouring Liberia.

The Phase III testing of the vaccine -- one of two that are in the most advanced stages of development -- aims to ensure it provides protection against the virus that has killed some 9 800 people in Liberia, Guinea and Sierra Leone.

There is no licensed treatment or vaccine for Ebola, and the WHO has endorsed rushing potential ones through trials in a bid to stem the epidemic.

Researchers have said that it remains unknown what level of immune response is needed to protect humans from Ebola, which causes often fatal haemorrhaging, organ failure and severe diarrhoea.

"If a vaccine is found [to be] effective, it will be the first preventive tool against Ebola in history," WHO Chief Margaret Chan said in a statement.

The two candidate vaccines currently being developed, CAd3 by Britain's GlaxoSmithKline and VSV-EBOV by Merck and NewLink Genetics have both passed safety tests on humans.

They are already being tested in Liberia, and the trial of VSV-EBOV will kick off in Guinea on 7 March, WHO said.

Vaccinations will take place in areas of Basse Guinee, the region that currently has the highest number of cases in the country, it added.

Authorities will use a so-called "ring vaccination" approach that was used to eradicate smallpox in the 1970s, tracking down anyone who could have been exposed to a newly diagnosed patient and vaccinating them if they agree.

Part of the contacts will be vaccinated immediately after the new case is detected, while others will be given a shot three weeks later, the length of the virus's incubation period.

"The Ebola epidemic shows signs of receding," said Marie-Paule Kieny, who leads the Ebola research and development effort at WHO.

In worst-hit Liberia, for instance, no new confirmed cases have been reported for a full week, WHO said, a first since May.

"But we cannot let down our guard until we reach zero cases," Kieny said in the statement.

"An effective vaccine to control current flare-ups could be the game-changer to finally end this epidemic and an insurance policy for any future ones."

Read more on:    who  |  guinea  |  west africa  |  ebola

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24


Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.